Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xeroderma pigmentosum

W C Lambert1, H R Kuo, M W Lambert

  • 1Department of Pathology, University of Medicine and Dentistry, New Jersey-New Jersey Medical School, Newark, USA.

Dermatologic Clinics
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perineal cutaneous basal cell carcinomas in patients with familial seronegative coeliac disease: report of three cases.

The British journal of dermatology·2021
Same author

Comparison of adult vs. paediatric inpatients with staphylococcal scalded skin syndrome: a retrospective database analysis.

The British journal of dermatology·2020
Same author

Prolonged overall survival following metastasectomy in stage IV melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Surgical management of localized melanoma: a national cancer database retrospective review.

The British journal of dermatology·2019
Same author

Declining recommended surgery in primary cutaneous melanoma: an analysis of risk factors and survival.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

How sildenafil (Viagra<sup>®</sup> ) may cause melanoma: a histopathologic study providing a potential physiological/etiopathological mechanism.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Xeroderma pigmentosum is a rare genetic disorder causing extreme sun sensitivity and early-onset skin cancers due to defective DNA repair. Research shows genetic heterogeneity and cloned genes are key to understanding this disease.

Area of Science:

  • Genetics
  • Molecular Biology
  • Dermatology

Background:

  • Xeroderma pigmentosum (XP) is a rare, autosomal recessive disorder.
  • XP patients exhibit extreme sensitivity to ultraviolet (UV) radiation.
  • This sensitivity leads to early-onset skin cancers and, in some cases, neurological deficits.

Purpose of the Study:

  • To summarize the cellular, biochemical, and molecular genetic findings in Xeroderma pigmentosum.
  • To highlight the defective DNA repair mechanisms in XP cells.
  • To underscore the genetic heterogeneity and cloned genes involved in XP.

Main Methods:

  • Cellular studies to assess DNA repair.
  • Biochemical analyses of DNA repair pathways.
  • Molecular genetic investigations, including gene cloning and characterization.

Related Experiment Videos

Main Results:

  • XP cells demonstrate impaired repair of UV-induced DNA damage.
  • Significant genetic heterogeneity exists, involving multiple distinct genes.
  • Several XP-associated genes and their protein products have been identified and cloned.

Conclusions:

  • Defective DNA repair is the primary defect in Xeroderma pigmentosum.
  • Understanding the cloned genes and their functions is crucial for diagnosing and potentially treating XP.
  • Further research into genetic heterogeneity may reveal new therapeutic targets.